| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 原料药系列(元) | 134,381,078.40 | 456,456,474.48 | 316,290,993.64 | 443,396,055.73 | 269,131,663.54 |
| 制剂药品系列(元) | 511,440,036.94 | 1,075,319,326.80 | 542,623,142.45 | 1,079,083,220.43 | 584,392,870.74 |
| 肠衣系列(元) | 76,781,256.14 | - | - | - | - |
| 其他(元) | 35,763,334.89 | 39,500,710.94 | 2,857,359.04 | 3,763,510.57 | 2,071,319.22 |
| 营业成本(元) | |||||
| 原料药系列(元) | 97,040,189.19 | 306,664,344.58 | 212,304,159.14 | 276,380,476.55 | 178,432,387.57 |
| 制剂药品系列(元) | 157,250,667.94 | 318,216,008.62 | 163,326,688.53 | 411,997,905.95 | 225,783,484.03 |
| 肠衣系列(元) | 68,885,776.47 | - | - | - | - |
| 其他(元) | 31,303,840.20 | 29,467,224.98 | 856,445.86 | 688,753.35 | 494,387.79 |
| 毛利(元) | |||||
| 原料药系列(元) | 37,340,889.21 | 149,792,129.90 | 103,986,834.50 | 167,015,579.18 | 90,699,275.97 |
| 制剂药品系列(元) | 354,189,369.00 | 757,103,318.18 | 379,296,453.92 | 667,085,314.48 | 358,609,386.71 |
| 肠衣系列(元) | 7,895,479.67 | - | - | - | - |
| 其他(元) | 4,459,494.69 | 10,033,485.96 | 2,000,913.18 | 3,074,757.22 | 1,576,931.43 |
| 毛利率(%) | |||||
| 原料药系列(%) | 27.79 | 32.82 | 32.88 | 37.67 | 33.70 |
| 制剂药品系列(%) | 69.25 | 70.41 | 69.90 | 61.82 | 61.36 |
| 肠衣系列(%) | 10.28 | - | - | - | - |
| 其他(%) | 12.47 | 25.40 | 70.03 | 81.70 | 76.13 |
| 收入构成(%) | |||||
| 原料药系列(%) | 17.72 | 29.05 | 36.70 | 29.05 | 31.46 |
| 制剂药品系列(%) | 67.44 | 68.44 | 62.97 | 70.70 | 68.30 |
| 肠衣系列(%) | 10.12 | - | - | - | - |
| 其他(%) | 4.72 | 2.51 | 0.33 | 0.25 | 0.24 |
| 毛利构成(%) | |||||
| 原料药系列(%) | 9.25 | 16.34 | 21.43 | 19.95 | 20.12 |
| 制剂药品系列(%) | 87.70 | 82.57 | 78.16 | 79.68 | 79.53 |
| 肠衣系列(%) | 1.95 | - | - | - | - |
| 其他(%) | 1.10 | 1.09 | 0.41 | 0.37 | 0.35 |
